NovaBay Pharmaceuticals, Inc.
Quick facts
Phase 2 pipeline
- Auriclosene Irrigation Solution, 0.2% · Dermatology
Auriclosene Irrigation Solution is a topical antimicrobial agent that kills bacteria and fungi by disrupting their cell membranes. - Auriclosene Solution 0.3%
- Experimental: CD07223 1.5 % Topical Gel BID
- Experimental: CD07223 1.5% Topical Gel TID · Infectious Diseases
CD07223 is an experimental drug that targets the bacterial cell wall synthesis pathway. - NVC-422
- NVC-422, 0.2%
- NVC-422 Solution, 0.3%
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies